Advertisement

Pulmonary Drug Delivery: An Historical Overview

  • Mark SandersEmail author
Chapter
Part of the Advances in Delivery Science and Technology book series (ADST)

Abstract

The history of pulmonary drug delivery is nearly as old as recorded history itself. The journey from these ancient times to today’s therapeutics and delivery systems is fascinating and provides an understanding of what has driven innovation. It is also critical to understand the evolving science and technology of pulmonary drug delivery and its trajectory from the current state of the art.

Keywords

Atomizer Dry powder inhaler History Inhalation Inhaler Nebulizer pMDI 

References

  1. 1.
    Beatson G (1880) On spray producers as used in lister’s antiseptic system. Edinburgh: MacLachlan & Stewart, pp 1–43Google Scholar
  2. 2.
    Bennet C (1654) Theatri tabidorum vestibulum: seu exercitationes dianoeticae cum historiis et experimentis demonstratives. London: Newcomb, pp 1–126Google Scholar
  3. 3.
    Berkart J (1878) On asthma: its pathology and treatment. London: Churchill, pp 1–264Google Scholar
  4. 4.
    Brewis R (1991) Classic papers in asthma, vol 2. Science Press, London, pp 1–214Google Scholar
  5. 5.
    British Pharmacopoeia (1867) London: Spottiswoode & Co. pp 1–434Google Scholar
  6. 6.
    Broadbent C (1862) A medical treatise on the causes and curability of consumption, laryngitis, chronic catarrh, and diseases of the air passages. Combining the treatment by inhalation of medicated vapors. Damrell Welch, BostonGoogle Scholar
  7. 7.
    Bryan C (1930) The papyrus ebers. London: Geoffrey BlesGoogle Scholar
  8. 8.
    Bullowa JJM, Kaplan DM (1903) On the hypodermic use of adrenalin chloride in the treatment of asthamatic attacks. Med News (NY) 83:787Google Scholar
  9. 9.
    Chambers TK (1848) The Lancet. London.Google Scholar
  10. 10.
    Chen K, Schmidt C (1924) The action of ephedrine, the active principle of the chinese drug Ma Huang. Pharm Exp Ther 24:339–357Google Scholar
  11. 11.
    Chen K, Schmidt C (1937) The action of ephidrine: the active principle of chinese drug Ma Huang. JAMA 109:1712Google Scholar
  12. 12.
    Cornell W (1850) Boston Med Surg JGoogle Scholar
  13. 13.
    Da Costa J (1867) Inhalations in the treatment of disease of the respiratory passages particularly as effected by the use of atomized fluids. Lippincott, PhiladelphiaGoogle Scholar
  14. 14.
    Ellis B (1864) The medical formulary. Philadelphia, pp 109–112Google Scholar
  15. 15.
    Evans G (1891) Notes on respiratory therapeutics. Brooklyn Med J 12:787–789Google Scholar
  16. 16.
    Gandevia B (1975) Historical review of the use of parasympathetic agents in the treatment of respiratory disorders. Postgrad Med 51(suppl 7):13–20Google Scholar
  17. 17.
    Gansslen M (1925) Uber inhalation von insulin. Klin Wocchenschr 4:71CrossRefGoogle Scholar
  18. 18.
    Gelfand M (1951) Administration of cortisone by the aerosol method in treatment of bronchial asthma. N Engl J Med 245:293PubMedCrossRefGoogle Scholar
  19. 19.
    Goldstein DS (2006) Adrenalin and the inner world. John Hopkins University Press, BaltimoreGoogle Scholar
  20. 20.
    Humphrey J (1819) Letter to Dr T. C. James. Eclectic Rep Anal Rev 9(2):259–260Google Scholar
  21. 21.
    Julius F (1862) On arsenic smoking in asthma, the retrospect of practical medicine and surgery. Part XLIV JanuaryGoogle Scholar
  22. 22.
    Krohne and Sesemann (1866) Letter in: British Med Feb 17:191Google Scholar
  23. 23.
    Lancet (1863) Dr Nelson’s improved earthenware inhaler. The Lancet Feb 11 1863:152Google Scholar
  24. 24.
    Maddock AB (1844) Practical observations on the efficacy of medicated inhalations in the treatment of pulmonary consumption, asthma, bronchitis, chronic cough and other diseases of the respiratory organs. Simpkin and Marshall, LondonGoogle Scholar
  25. 25.
    Muntner S (1963) Treatise on asthma by Maimonides. Philadelphia: Lippincott, pp 1–115Google Scholar
  26. 26.
    Mann RD (1984) Modern drug use. An inquiry on historical principles. MTP, LancasterGoogle Scholar
  27. 27.
    Matthieu M (1859) Gazette des Hôpitaux. Paris p 297Google Scholar
  28. 28.
    McFadden ER Jr (1986) Inhaled aerosol bronchodilators. Williams & Williams, BaltimoreGoogle Scholar
  29. 29.
    Mudge J (1778) A radical and expeditious cure for a recent catarrhous cough. London: Allen, pp 1–252Google Scholar
  30. 30.
    Nerbrink O (2003) A history of the development of therapy by jet nebulisation. In: Gradoń L, Marijnissen J (eds) Optimization of aerosol drug delivery, p 18Google Scholar
  31. 31.
    Newton A (1864) Inhaling Apparatus UK patent 1161Google Scholar
  32. 32.
    Osler W (1898) The principles and practice of medicine. D. Appleton & Co., New YorkGoogle Scholar
  33. 33.
    Osler W, McCrae T (1914) Bronchial asthma. In: The principles and practice of medicine, 8th ed. D. Appleton & Co., New York, pp 627–631Google Scholar
  34. 34.
    Pick L (1911) The action of adrenalin preparations. Bronchial asthma. Medizinische Klinik; No. 5Google Scholar
  35. 35.
    Sales-Girons (1858) Thérapeutique Respiratoire: Traité Théorique et Pratique des Salles de Respiration Nouvelles à l’eau Minérale Pulvérisée, pour le traitement des Maladies de Poitrine. Paris: Adrien Delahaye, pp 1–194Google Scholar
  36. 36.
    Salter H (1860) On asthma: its pathology and treatment. John Churchill, LondonGoogle Scholar
  37. 37.
    Scudamore C (1834) Cases illustrating and confirming the remedial power of the inhalation of iodine and conium in tubercular phthisis and various disordered states of the lungs and air passages. London: Longman, pp 1–227Google Scholar
  38. 38.
    Siegle EA (1864) Steam spray producer for inhalation. Patent April 22nd. Kroner, StuttgartGoogle Scholar
  39. 39.
    Sims J (1812) Datura stramonium or thorn apple as a cure or relief of asthma. Edinburgh Med Surg J 8:364–367Google Scholar
  40. 40.
    Snell N (2001) The carbolic smoke ball. Int J Pharm Med 15:195–196Google Scholar
  41. 41.
    Solis Cohen J (1867) Inhalation: its therapeutics and practice. Philadelphia: Lindsay & BlakistonGoogle Scholar
  42. 42.
    Solis Cohen S (1899) A preliminary note on the treatment of hay-fever with suprarenal substance: with a report of personal experience. Philadelphia Med J 2:341–343Google Scholar
  43. 43.
    Solis Cohen S (1900) The use of adrenal substance in the treatment of asthma. JAMA 34:1164–1166Google Scholar
  44. 44.
    Stern P (1767) Medical advice to the consumptive and asthmatic peoples of England. London: AlmonGoogle Scholar
  45. 45.
    Thomas RH (1855) Transactions of the American Medical Association, vol. Viii, p 591Google Scholar
  46. 46.
    Thomas WS (1926) Ephedrin in asthma: a clinical report. Am J Med Sci 171:179CrossRefGoogle Scholar
  47. 47.
    Trousseau A (1867) Lectures on clinical medicine delivered at hotel-Dieu, Paris. Vol. 1 London: Hardwicke, pp 1–712Google Scholar

Copyright information

© Controlled Release Society 2011

Authors and Affiliations

  1. 1.Clement Clarke International LtdDunstableUK

Personalised recommendations